NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
NovoCure (NVCR) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 9.80% |
| 10 | NovoCure | 1.63 Bn | 1.20 Bn | 135.13 Mn | 27.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.90% |
| Dec 31, 2025 | 33.42% |
| Sep 30, 2025 | 39.05% |
| Jun 30, 2025 | 44.62% |
| Mar 31, 2025 | 46.97% |
| Dec 31, 2024 | 50.70% |
| Sep 30, 2024 | 84.31% |
| Jun 30, 2024 | 77.65% |
| Mar 31, 2024 | 71.24% |
| Dec 31, 2023 | 65.31% |
| Sep 30, 2023 | 64.31% |
| Jun 30, 2023 | 57.52% |
| Mar 31, 2023 | 55.06% |
| Dec 31, 2022 | 51.80% |
| Sep 30, 2022 | 52.27% |
| Jun 30, 2022 | 46.78% |
| Mar 31, 2022 | 43.86% |
| Dec 31, 2021 | 39.04% |
| Sep 30, 2021 | 10.96% |
| Jun 30, 2021 | 10.07% |